XML 105 R89.htm IDEA: XBRL DOCUMENT v3.8.0.1
SCHEDULE II Condensed Balance Sheets (Details) - USD ($)
$ in Thousands
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Assets        
Cash and cash equivalents $ 27,285 $ 39,858 $ 112,162 $ 12,030
Notes receivable, net 28,497 33,734    
Total assets 3,357,393 2,664,693    
Liabilities        
Total liabilities 2,505,967 1,773,006    
Equity        
Share capital 3,736 3,737    
Additional paid-in capital 503,316 500,337    
Retained earnings 324,272 370,168    
Shareholders’ equity attributable to shareholders 831,324 874,242    
Total liabilities, redeemable non-controlling interest and equity 3,357,393 2,664,693    
Parent Company        
Assets        
Cash and cash equivalents 84 6 $ 6 $ 1
Investment in subsidiaries 815,009 888,095    
Notes receivable, net 15,355 15,164    
Due from subsidiaries 876 0    
Total assets 831,324 903,265    
Liabilities        
Due to subsidiaries 0 29,023    
Total liabilities 0 29,023    
Equity        
Share capital 3,736 3,737    
Additional paid-in capital 503,316 500,337    
Retained earnings 324,272 370,168    
Shareholders’ equity attributable to shareholders 831,324 874,242    
Total liabilities, redeemable non-controlling interest and equity $ 831,324 $ 903,265